UBE2I and cancer: Indeed, the essential SUMO conjugating enzyme UBC9 is a central protein for many cellular activities and could also be a fundamental driver of cancer growth since it is altered in a variety of human malignancies [21], and thus a putative candidate for drug therapy [57].